TLRY

Q: What is the price of Tilray (TLRY) today?

The price of Tilray (TLRY) today is $ 6.73, with return of -0.4% compared to the last year. The price of Tilray (TLRY) started the year trading around $ 9.03 and today it is at $ 6.73. Follow the real-time price chart, the historical price of Tilray (TLRY) and international markets.

Q: When does Tilray (TLRY) pay dividends?

Tilray (TLRY) did not distribute dividends in the last year.

Q: Is Tilray (TLRY) worth it?

Currently, Tilray (TLRY) is priced at $ 6.73, with a P/E of -0.36%, representing a deviation of 689% from its historical average P/E. In the last year, the stock showed a variation of -0.4 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was -0.40%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Tilray (TLRY) stock?

Investing in stocks of Tilray (TLRY) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Tilray (TLRY) yield today?

The yield of Tilray (TLRY) was -10.39% in the last month, -0.40% in the last year and 0.00% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of Tilray (TLRY) today, the total investment would be $ 673.00, based on the current price of $ 6.73.If past performance were to repeat, the return on your investment would be:In 1 year: $ 670.31In 5 years: $ 673.00In 10 years: $ 673.00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Tilray Inc.

Price

$ 6.73

return (12m)

-0.40%

p/e

-0.36

p/bv

0.49

DIVIDEND YIELD

0.00%

TLRY price

TLRY

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment TLRY

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-10.39%

3 months

-45.46%

1 year

-0.40%

2 years

-64.95%

5 years

0.00%

10 years

0.00%

Fundamentals TLRY

review the fundamentals of Tilray shares

P/E

-0.36

Sector: -2.05 Industry: 0.45

P/S (PSR)

0.91

Sector: 1.91 Industry: 2.40

P/BV

0.49

Sector: 2.15 Industry: 2.31

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-100.42%

Sector: -26.68% Industry: -25.20%

ROE

-136.27%

Sector: -30.10% Industry: -31.06%

ROIC

-5.05%

Sector: -419.47% Industry: -79.64%

NET MARGIN

-100.00%

Sector: -28.71% Industry: -29.75%

GROSS MARGIN

28.02%

Sector: 44.63% Industry: 50.65%

OPERATING MARGIN

-8.95%

Sector: -24.00% Industry: -25.98%

EV/EBITDA

-0.36

Sector: -0.49 Industry: 1.22

EV/EBIT

-0.35

Sector: -2.22 Industry: -0.99

PRICE-TO-ASSETS

0.36

Sector: 1.16 Industry: 1.26

BVPS

14.06

Sector: 3.53 Industry: 4.84

EPS

-19.16

Sector: -0.92 Industry: -0.84

EQUITY-TO-ASSETS RATIO

0.74

Sector: 0.43 Industry: 0.45

LIABILITIES / ASSETS

0.26

Sector: 0.47 Industry: 0.51

CAGR REVENUE 5 YEARS

7.28%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

50.27%

Sector: - Industry: -

Fundamentals TLRY

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	42.72	36.97	86.53%	0.63%	$ 881.65 B	31.66%
ISRG	58.69	9.34	15.92%	0.00%	$ 167.62 B	28.38%
TMO	26.04	3.26	12.52%	0.37%	$ 174.60 B	15.05%
SNY	11.67	1.27	10.86%	5.07%	$ 106.43 B	18.68%
NVS	21.01	6.31	30.04%	4.54%	$ 293.84 B	24.67%
ABT	31.01	3.95	12.73%	2.06%	$ 202.33 B	14.72%
MDT	24.24	2.27	9.38%	3.25%	$ 111.80 B	13.00%
CVS	54.69	1.28	2.35%	3.49%	$ 96.69 B	0.44%
GSK	14.07	5.02	35.71%	3.12%	$ 107.31 B	17.48%
BSX	35.38	0.00	0.00%	0.00%	$ 102.52 B	14.44%
TMDX	22.06	8.87	40.22%	0.00%	$ 4.20 B	31.43%
HCA	17.91	-43.85	-244.82%	0.54%	$ 121.52 B	8.97%
IDXX	43.33	28.59	65.99%	0.00%	$ 45.91 B	24.62%
RMD	22.68	5.33	23.51%	1.24%	$ 33.70 B	27.53%
DHR	36.65	2.52	6.88%	0.68%	$ 132.44 B	14.71%
INMD	9.09	1.25	13.73%	0.00%	$ 853.02 M	25.32%
PHG	25.47	2.05	8.06%	3.19%	$ 26.43 B	5.07%
FMS	11.55	0.78	6.75%	3.45%	$ 13.04 B	5.02%
SYK	39.63	5.74	14.48%	1.01%	$ 128.65 B	12.92%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

TLRY Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Tilray

Tilray Inc.

Average Investor10 user rating

4.0 (12 people)

United States

15 years

Founded: 2011

2015

Time since IPO - 11 years

2.100

Employees

Tilray Inc. (TLRY) is a company operating in the cannabis and cannabinoid-based products industry. The company develops, cultivates, processes and distributes cannabis products for medical and consumer markets.

Its operations include a diversified portfolio of cannabis and related consumer products distributed across regulated markets.

Its main activities include:

• Cultivation and processing of medical and adult-use cannabis.
• Production of cannabis oils, dried flower and cannabinoid extracts.
• Development of CBD and hemp-based consumer products.
• Distribution of cannabis products through licensed medical and retail channels.

Tilray operates internationally with activities across North America, Europe and other regulated markets, supplying products through pharmacies, authorized distributors and retail networks where cannabis use is legally permitted.

Industry dynamics affecting the company include regulatory changes, expansion of legal cannabis markets, consumer demand for cannabis-based products and competition from other global cannabis producers.

Tilray Inc. trades on the Nasdaq under the ticker TLRY.

History and Development

Tilray Inc. was founded in 2013 in British Columbia, Canada, becoming one of the early licensed producers of medical cannabis under Canada’s regulatory framework.

The company expanded internationally during the mid-2010s, establishing operations and distribution channels in several regulated markets.

Tilray completed its initial public offering (IPO) in 2018 on the Nasdaq, becoming one of the first cannabis companies to list on a major U.S. exchange.

In 2021, Tilray merged with Aphria, creating one of the largest cannabis companies globally and expanding its production capacity and product portfolio.

Additional Information

The Company Tilray Inc. (United States), is listed on Nasdaq with a market value of $ 757.90 Millions, having an equity of $ 1.55 Billion.

With a total of 2.100 employees, the company is listed in the sector of Health and categorized in industry of Pharmaceutical Products.

In the last 12 months the Company had a revenue of $ 837.32 Millions, which generated a loss in the amount of $ -2.11 Billions.

As for its main indicators, the Company has a P/E ratio of -0.36, a P/BV ratio of 0.49 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker TLRY.

Market cap

$ 757.90 Millions

Net worth

$ 1.55 Billion

US$ 1,546,510,000.00

Assets

$ 2.10 Billions

US$ 2,098,600,000.00

Total Shares Outstanding

110.00 Millions

110,000,000

Average Daily Trading Volume

$ 3.96 Millions

US$ 3,964,221.54

Sector

Health

Industry

Pharmaceutical Products

TLRY

TLRY revenue and profits

Financial Results TLRY

DRAG THE FRAME TO SEE MORE DATA

TLRY cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$ 73.02 11,63% (12M)

P/E

54.69

3.49%

ROE

2.35%

P/BV

1.28

CI - Cigna

$ 264.61 --15,78% (12M)

P/E

10.34

2.26%

ROE

0.00%

P/BV

0.00

CNC - Centene

$ 36.16 --38,95% (12M)

P/E

-2.54

0.00%

ROE

-33.28%

P/BV

0.85

HUM - Humana

$ 170.42 --35,04% (12M)

P/E

16.71

2.14%

ROE

6.70%

P/BV

1.12

HCA - HCA Healthcare

$ 502.05 51,60% (12M)

P/E

17.91

0.54%

ROE

-244.82%

P/BV

-43.85

LLY - Eli Lilly

$ 918.05 9,75% (12M)

P/E

42.72

0.63%

ROE

86.53%

P/BV

36.97

NVS - Novartis

$ 149.81 41,84% (12M)

P/E

21.01

4.54%

ROE

30.04%

P/BV

6.31